{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:38:53Z","timestamp":1792784333246,"version":"4.5.0"},"reference-count":183,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["3100AO-100309"],"award-info":[{"award-number":["3100AO-100309"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["3100AO-116719"],"award-info":[{"award-number":["3100AO-116719"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Swiss Federal Institute of Technology","award":["11 07\/03"],"award-info":[{"award-number":["11 07\/03"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.neuropharm.2011.01.009","type":"journal-article","created":{"date-parts":[[2011,1,15]],"date-time":"2011-01-15T04:16:45Z","timestamp":1295065005000},"page":"1308-1321","source":"Crossref","is-referenced-by-count":227,"title":["To poly(I:C) or not to poly(I:C): Advancing preclinical schizophrenia research through the use of prenatal immune activation models"],"prefix":"10.1016","volume":"62","author":[{"given":"Urs","family":"Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joram","family":"Feldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2011.01.009_bib1","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.biopsych.2010.09.022","article-title":"Prenatal interaction of mutant DISC1 and immune activation produces adult psychopathology","volume":"68","author":"Abazyan","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib2","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kB by toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neuron.2006.09.023","article-title":"Modeling madness in mice: one piece at a time","volume":"52","author":"Arguello","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib4","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.bbr.2009.04.010","article-title":"Animal models of gene-environment interactions in schizophrenia","volume":"204","author":"Ayhan","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib5","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1176\/ajp.2006.163.5.927","article-title":"Prenatal exposure to maternal genital and reproductive infections and adult schizophrenia","volume":"163","author":"Babulas","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/schbul\/sbn154","article-title":"CNTRICS final task selection: executive control","volume":"35","author":"Barch","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/schbul\/sbn163","article-title":"Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meeting","volume":"35","author":"Barch","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.schres.2007.05.030","article-title":"Reaction time and sustained attention in schizophrenia and its genetic predisposition","volume":"95","author":"Birkett","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib9","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1038\/npp.2010.129","article-title":"Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia","volume":"35","author":"Bitanihirwe","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib10","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1017\/S1461145710000192","article-title":"Cognitive impairment following prenatal immune challenge in mice correlates with prefrontal cortical AKT1 deficiency","volume":"13","author":"Bitanihirwe","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib11","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1176\/ajp.2006.163.10.1838","article-title":"Ethical concerns regarding olanzapine versus placebo in patients prodromally symptomatic for psychosis","volume":"163","author":"Block","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4000815","article-title":"Association between -G308A tumor necrosis factor alpha gene polymorphism and schizophrenia","volume":"6","author":"Boin","year":"2001","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib13","first-page":"8","article-title":"Of rats and schizophrenia","volume":"32","author":"Boksa","year":"2007","journal-title":"J.\u00a0Psychiatry Neurosci."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib14","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.bbi.2010.03.005","article-title":"Effects of prenatal infection on brain development and behavior: a review of findings from animal models","volume":"24","author":"Boksa","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib15","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0893-133X(01)00360-8","article-title":"Prenatal immune challenge disrupts sensorimotor gating in adult rats: implications for the etiopathogenesis of schizophrenia","volume":"6","author":"Borrell","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib16","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s002130100810","article-title":"Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies","volume":"156","author":"Braff","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/schbul\/sbj052","article-title":"Prenatal infection as a risk factor for schizophrenia","volume":"32","author":"Brown","year":"2006","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib18","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/archpsyc.61.8.774","article-title":"Serologic evidence of prenatal influenza in the etiology of schizophrenia","volume":"61","author":"Brown","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0006-3223(01)01068-X","article-title":"A.E. Bennett Research Award. Prenatal rubella, premorbid abnormalities, and adult schizophrenia","volume":"49","author":"Brown","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1176\/appi.ajp.2009.09030361","article-title":"Prenatal infection and schizophrenia: a review of epidemiologic and translational studies","volume":"167","author":"Brown","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/mrdd.10004","article-title":"In utero infection and adult schizophrenia","volume":"8","author":"Brown","year":"2002","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib22","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0166-2236(02)02164-1","article-title":"Rodent models of prefrontal cortical function","volume":"25","author":"Brown","year":"2002","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib23","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/schbul\/sbm083","article-title":"Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia","volume":"33","author":"Buchanan","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib24","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/1096-8628(20001204)96:6<808::AID-AJMG23>3.0.CO;2-E","article-title":"Nurr1 mutations in cases of SZ and manic-depressive disorder","volume":"96","author":"Buervenich","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib25","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/oxfordjournals.schbul.a007037","article-title":"Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions","volume":"29","author":"Cannon","year":"2003","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.pharmtox.41.1.237","article-title":"Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence","volume":"41","author":"Carlsson","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00213-003-1710-9","article-title":"Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia","volume":"174","author":"Castner","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib28","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.biopsych.2008.05.009","article-title":"Set-shifting ability and schizophrenia: a marker of clinical illness or an intermediate phenotype?","volume":"64","author":"Ceaser","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib29","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0006-3223(01)01324-5","article-title":"Association between promoter polymorphic haplotypes of interleukin-10 gene and schizophrenia","volume":"51","author":"Chiavetto","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0306-4522(01)00171-3","article-title":"Translating developmental time across mammalian species","volume":"105","author":"Clancy","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib31","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.neuro.2007.01.014","article-title":"Extrapolating brain development from experimental species to humans","volume":"28","author":"Clancy","year":"2007","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1385\/NI:5:1:79","article-title":"Web-based method for translating neurodevelopment from laboratory species to humans","volume":"5","author":"Clancy","year":"2007","journal-title":"Neuroinformatics"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib33","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/schbul\/sbm163","article-title":"Does the concept of \u201csensitization\u201d provide a plausible mechanism for the putative link between the environment and schizophrenia?","volume":"34","author":"Collip","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib34","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/oxfordjournals.schbul.a007038","article-title":"The stress cascade and schizophrenia: etiology and onset","volume":"29","author":"Corcoran","year":"2003","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib35","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4088\/JCP.v68n0410","article-title":"Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents","volume":"68","author":"Cornblatt","year":"2007","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib36","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.neuron.2008.03.001","article-title":"Behavioral phenotyping strategies for mutant mice","volume":"57","author":"Crawley","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/schbul\/23.1.63","article-title":"Perseveration in schizophrenia","volume":"23","author":"Crider","year":"1997","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib38","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.bbi.2006.12.007","article-title":"The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C)","volume":"21","author":"Cunningham","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib39","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.neubiorev.2004.09.006","article-title":"Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates","volume":"28","author":"Dalley","year":"2004","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib40","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1176\/appi.ajp.157.5.772","article-title":"Continuous performance test and schizophrenia: a test of stimulus-response compatibility, working memory, response readiness, or none of the above?","volume":"157","author":"Elvev\u00e5g","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib41","series-title":"Neuropsychiatric Disorders and Infection","author":"Fatemi","year":"2005"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0920-9964(03)00175-0","article-title":"Glial fibrillary acidic protein and glutamic acid decarboxylase 65 and 67\u00a0kDa proteins are increased in brains of neonatal BALB\/c mice following viral infection in utero","volume":"69","author":"Fatemi","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib43","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/00001756-200005150-00026","article-title":"Prenatal viral infection causes alterations in nNOS expression in developing mouse brains","volume":"11","author":"Fatemi","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib44","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.mp.4000520","article-title":"Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice","volume":"4","author":"Fatemi","year":"1999","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib45","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/sj.mp.4001046","article-title":"Human influenza viral infection in utero alters glial fibrillary acidic protein immunoreactivity in the developing brains of neonatal mice","volume":"7","author":"Fatemi","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib46","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/schbul\/sbn187","article-title":"The neurodevelopmental hypothesis of schizophrenia, revisited","volume":"35","author":"Fatemi","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib47","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.schres.2009.04.014","article-title":"Abnormal expression of myelination genes and alterations in white matter fractional anisotropy following prenatal viral influenza infection at E16 in mice","volume":"112","author":"Fatemi","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.schres.2007.11.018","article-title":"Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders","volume":"99","author":"Fatemi","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib49","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/(SICI)1098-2396(199805)29:1<84::AID-SYN8>3.0.CO;2-7","article-title":"Human influenza viral infection in utero increases nNOS expression in hippocampi of neonatal mice","volume":"29","author":"Fatemi","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(98)00450-8","article-title":"Differential expression of synaptosome-associated protein 25\u00a0kDa [SNAP-25] in hippocampi of neonatal mice following exposure to human influenza virus in utero","volume":"800","author":"Fatemi","year":"1998","journal-title":"Brain Res."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2011.01.009_bib51","first-page":"A15","article-title":"Synergistic interaction between prenatal immune challenge and peri-pubertal stress in the disruption of adult behavioral functions relevant to schizophrenia","volume":"44","author":"Feldon","year":"2010","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib52","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0022-3956(92)90040-U","article-title":"From an animal model of an attentional deficit towards new insights into the pathophysiology of schizophrenia","volume":"26","author":"Feldon","year":"1992","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib53","doi-asserted-by":"crossref","first-page":"R759","DOI":"10.1152\/ajpregu.00293.2004","article-title":"The viral mimic, polyinosinic:polycytidylic acid, induces fever in rats via an interleukin-1-dependent mechanism","volume":"287","author":"Fortier","year":"2004","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib54","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.bbr.2007.04.016","article-title":"Effects of prenatal infection on prepulse inhibition in the rat depend on the nature of the infectious agent and the stage of pregnancy","volume":"181","author":"Fortier","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib55","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/mp.2009.108","article-title":"Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis","volume":"16","author":"Fusar-Poli","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbr.2006.06.002","article-title":"Animal neuropsychology: validation of the Intra-Dimensional Extra-Dimensional set shifting task for mice","volume":"173","author":"Garner","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib57","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0920-9964(96)00123-5","article-title":"Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia","volume":"24","author":"Gilmore","year":"1997","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib58","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jneuroim.2004.10.008","article-title":"Maternal poly I:C exposure during pregnancy regulates TNF alpha, BDNF, and NGF expression in neonatal brain and the maternal-fetal unit of the rat","volume":"159","author":"Gilmore","year":"2005","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib59","series-title":"Psychopathology in the Brain","article-title":"Prefrontal cortical dysfunction in working memory: the relevance of working memory","author":"Goldman-Rakic","year":"1991"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib60","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1176\/jnp.6.4.348","article-title":"Working memory dysfunction in schizophrenia","volume":"6","author":"Goldman-Rakic","year":"1994","journal-title":"J.\u00a0Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib61","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11920-010-0124-8","article-title":"Alterations of cortical GABA neurons and network oscillations in schizophrenia","volume":"12","author":"Gonzalez-Burgos","year":"2010","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib62","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/schbul\/sbn070","article-title":"GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia","volume":"34","author":"Gonzalez-Burgos","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0140525X00065055","article-title":"The neuropsychology of schizophrenia","volume":"14","author":"Gray","year":"1991","journal-title":"Behav. Brain Sci."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib64","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0920-9964(97)00118-7","article-title":"The onset of schizophrenia","volume":"28","author":"Gross","year":"1997","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7742(06)78001-1","article-title":"Neurobiology of dopamine in schizophrenia","volume":"78","author":"Guillin","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"issue":"Suppl. 2","key":"10.1016\/j.neuropharm.2011.01.009_bib66","first-page":"1","article-title":"Hormonal aspects of schizophrenias: an overview","volume":"28","author":"Halbreich","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib67","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/schbul\/sbj007","article-title":"Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research","volume":"32","author":"Haroun","year":"2006","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib68","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/sj.mp.4001558","article-title":"Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence","volume":"10","author":"Harrison","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib69","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/schbul\/sbn108","article-title":"Gene-environment interplay between cannabis and psychosis","volume":"34","author":"Henquet","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib70","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The dopamine hypothesis of schizophrenia: version III\u2014the final common pathway","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/archgenpsychiatry.2008.514","article-title":"Elevated striatal dopamine function linked to prodromal signs of schizophrenia","volume":"66","author":"Howes","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib72","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/schbul\/sbm168","article-title":"What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia","volume":"34","author":"Hulshoff Pol","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib73","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbr.2009.08.027","article-title":"Combined effect of neonatal immune activation and mutant DISC1 on phenotypic changes in adulthood","volume":"206","author":"Ibi","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib183","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pneurobio.2005.09.001","article-title":"The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease","volume":"77","author":"Jankovic","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib74","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0006-3223(92)90078-E","article-title":"Loss of the Kamin blocking effect in acute but not chronic schizophrenics","volume":"32","author":"Jones","year":"1992","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib75","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.med.52.1.503","article-title":"Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia","volume":"52","author":"Kapur","year":"2001","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib76","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tins.2009.02.003","article-title":"Modeling cognitive endophenotypes of schizophrenia in mice","volume":"32","author":"Kellendonk","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib77","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0022-3956(99)00033-3","article-title":"Development, disease and degeneration in schizophrenia: a unitary pathophysiological model","volume":"33","author":"Keshavan","year":"1999","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib78","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1017\/S0954579499002199","article-title":"Brain maturational processes and delayed onset in schizophrenia","volume":"11","author":"Keshavan","year":"1999","journal-title":"Dev. Psychopathol."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib79","first-page":"R1596","article-title":"Comparison of acute phase responses induced in rabbits by lipopolysaccharide and double-stranded RNA","volume":"267","author":"Kimura","year":"1994","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib80","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1001\/archpsyc.58.2.158","article-title":"Diagnosing schizophrenia in the initial prodromal phase","volume":"58","author":"Klosterk\u00f6tter","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib81","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/026988119701100205","article-title":"Dopamine, the prefrontal cortex and schizophrenia","volume":"11","author":"Knable","year":"1997","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib82","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.neuroimage.2004.03.051","article-title":"Sex-specific, postpuberty changes in mouse brain structures revealed by three-dimensional magnetic resonance microscopy","volume":"22","author":"Koshibu","year":"2004","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib83","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.clp.2005.04.009","article-title":"Influenza and pneumonia in pregnancy","volume":"32","author":"Laibl","year":"2005","journal-title":"Clin. Perinatol."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib84","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0165-0173(99)00054-5","article-title":"The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies","volume":"31","author":"Laruelle","year":"2000","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib85","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1177\/026988119901300405","article-title":"Dopamine as the wind of psychotic fire: new evidence from brain imaging studies","volume":"13","author":"Laruelle","year":"1999","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib86","doi-asserted-by":"crossref","first-page":"9235","DOI":"10.1073\/pnas.93.17.9235","article-title":"Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects","volume":"93","author":"Laruelle","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib87","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1196\/annals.1300.063","article-title":"Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment","volume":"1003","author":"Laruelle","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib88","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0920-9964(99)00232-7","article-title":"Executive\/attentional performance and measures of schizotypy in patients with schizophrenia and in their nonpsychotic first-degree relatives","volume":"46","author":"Laurent","year":"2000","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib89","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0165-1781(99)00109-2","article-title":"Attentional deficits in patients with schizophrenia and in their non-psychotic first-degree relatives","volume":"89","author":"Laurent","year":"1999","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib90","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrn1648","article-title":"Cortical inhibitory neurons and schizophrenia","volume":"6","author":"Lewis","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib91","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.neuro.25.112701.142754","article-title":"Schizophrenia as a disorder of neurodevelopment","volume":"25","author":"Lewis","year":"2002","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib92","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1192\/bjp.160.2.179","article-title":"Patterns of cerebral blood flow in schizophrenia","volume":"160","author":"Liddle","year":"1992","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib93","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF00216006","article-title":"Provocative tests with psychostimulant drugs in schizophrenia","volume":"91","author":"Lieberman","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib94","first-page":"98","article-title":"Neurodevelopmental animal models of schizophrenia","volume":"3","author":"Lillrank","year":"1995","journal-title":"Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib95","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0893-133X(00)00137-8","article-title":"To model a psychiatric disorder in animals: schizophrenia as a reality test","volume":"23","author":"Lipska","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib96","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/1029842021000022089","article-title":"A\u00a0neurodevelopmental model of schizophrenia: neonatal disconnection of the hippocampus","volume":"4","author":"Lipska","year":"2002","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib97","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbr.2009.01.031","article-title":"Gestational methylazoxymethanol acetate administration: a developmental disruption model of schizophrenia","volume":"204","author":"Lodge","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib98","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/GCO.0b013e328028fdc7","article-title":"Viral respiratory disease in pregnancy","volume":"19","author":"Longman","year":"2007","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib99","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.neuron.2007.04.014","article-title":"What is a schizophrenic mouse?","volume":"54","author":"Low","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib100","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/schbul\/sbi005","article-title":"Construct validity of the animal latent inhibition model of selective attention deficits in schizophrenia","volume":"31","author":"Lubow","year":"2005","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib182","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/ajhp\/59.suppl_5.S4","article-title":"Comprehensive understanding of schizophrenia and its treatment","volume":"59","author":"Maguire","year":"2002","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib101","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/schbul\/22.2.327","article-title":"Early detection and intervention in schizophrenia: research","volume":"22","author":"McGlashan","year":"1996","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib102","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archpsyc.1992.01820010063008","article-title":"The positive-negative distinction in schizophrenia. Review of natural history validators","volume":"49","author":"McGlashan","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib103","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0920-9964(02)00439-5","article-title":"The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design","volume":"61","author":"McGlashan","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib104","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1176\/ajp.2006.163.5.790","article-title":"Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis","volume":"163","author":"McGlashan","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib105","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/07853890310010005","article-title":"The neurodevelopmental hypothesis of schizophrenia: a review of recent developments","volume":"35","author":"McGrath","year":"2003","journal-title":"Ann. Med."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib106","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/archpsyc.1988.01800260109013","article-title":"Adult schizophrenia following prenatal exposure to an influenza epidemic","volume":"45","author":"Mednick","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib107","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bbr.2008.12.022","article-title":"Neural basis of psychosis-related behaviour in the infection model of schizophrenia","volume":"204","author":"Meyer","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib108","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00213-009-1504-9","article-title":"Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia","volume":"206","author":"Meyer","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib109","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.pneurobio.2009.10.018","article-title":"Epidemiology-driven neurodevelopmental animal models of schizophrenia","volume":"90","author":"Meyer","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib110","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.neubiorev.2009.05.001","article-title":"In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders","volume":"33","author":"Meyer","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib111","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neubiorev.2004.10.012","article-title":"Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia","volume":"29","author":"Meyer","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib112","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.bbi.2005.11.003","article-title":"Immunological stress at the maternal-foetal interface: a link between neurodevelopment and adult psychopathology","volume":"20","author":"Meyer","year":"2006","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib113","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/schbul\/sbn022","article-title":"A\u00a0review of the fetal brain cytokine imbalance hypothesis of schizophrenia","volume":"35","author":"Meyer","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib114","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00213-009-1754-6","article-title":"Chronic clozapine treatment improves prenatal infection-induced working memory deficits without influencing adult hippocampal neurogenesis","volume":"208","author":"Meyer","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib115","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/sj.mp.4002042","article-title":"Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling","volume":"13","author":"Meyer","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib116","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1523\/JNEUROSCI.0099-06.2006","article-title":"The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology","volume":"26","author":"Meyer","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib117","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/sj.npp.1301413","article-title":"Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge","volume":"33","author":"Meyer","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib118","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbi.2007.09.012","article-title":"Adult brain and behavioral pathological markers of prenatal immune challenge during early\/middle and late fetal development in mice","volume":"22","author":"Meyer","year":"2008","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib119","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00221-006-0419-5","article-title":"Prenatal and postnatal maternal contributions in the infection model of schizophrenia","volume":"173","author":"Meyer","year":"2006","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib120","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/schbul\/sbn131","article-title":"Evaluating early preventive antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia","volume":"36","author":"Meyer","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib121","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/1073858406296401","article-title":"The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse?","volume":"13","author":"Meyer","year":"2007","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib122","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-3956(02)00099-7","article-title":"Reduced Kamin blocking in non paranoid schizophrenia: associations with schizotypy","volume":"37","author":"Moran","year":"2003","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib123","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pnpbp.2007.07.021","article-title":"Abnormal prediction error is associated with negative and depressive symptoms in schizophrenia","volume":"32","author":"Moran","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib124","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.schres.2006.01.024","article-title":"Stereotypy in schizophrenia","volume":"84","author":"Morrens","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib125","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0165-0173(00)00026-6","article-title":"The pharmacology of latent inhibition as an animal model for schizophrenia","volume":"33","author":"Moser","year":"2000","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib126","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/schbul\/sbn078","article-title":"Reinforcement and reversal learning in first-episode psychosis","volume":"34","author":"Murray","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib127","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/schbul\/18.2.319","article-title":"A\u00a0neurodevelopmental approach to the classification of schizophrenia","volume":"18","author":"Murray","year":"1992","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib128","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/bmj.295.6600.681","article-title":"Is schizophrenia a neurodevelopmental disorder?","volume":"295","author":"Murray","year":"1987","journal-title":"BMJ"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib129","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.biopsych.2005.07.031","article-title":"Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia","volume":"59","author":"Ozawa","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib130","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbr.2008.12.016","article-title":"Immune involvement in schizophrenia and autism: etiology, pathology and animal models","volume":"204","author":"Patterson","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib131","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1176\/appi.ajp.162.10.1785","article-title":"Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis","volume":"162","author":"Perkins","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib132","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1080\/j.1440-1614.2006.01877.x","article-title":"Stress, the hippocampus and the hypothalamic-pituitary-adrenal axis: implications for the development of psychotic disorders","volume":"40","author":"Phillips","year":"2006","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib133","unstructured":"Piontkewitz, Y., Arad, M., Weiner, I. Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia. Schizophr. Bull., in press. (Epub ahead of print [PMID: 20439320])."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib134","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.biopsych.2009.07.005","article-title":"Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia","volume":"66","author":"Piontkewitz","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib135","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/sj.mp.4001642","article-title":"The neurodevelopmental model of schizophrenia: update 2005","volume":"10","author":"Rapoport","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib136","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/11530250-000000000-00000","article-title":"Progress in defining optimal treatment outcome in schizophrenia","volume":"24","author":"Remington","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib137","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0301-0082(94)90039-6","article-title":"The psychology of perserverative and stereotyped behaviour","volume":"44","author":"Ridley","year":"1994","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib138","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/sj.mp.4001993","article-title":"Adult mice with reduced Nurr1 expression: an animal model for schizophrenia","volume":"12","author":"Rojas","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib139","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1038\/sj.npp.1301292","article-title":"Neurobehavioral and immunological consequences of prenatal immune activation in rats. Influence of antipsychotics","volume":"32","author":"Romero","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib140","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1073\/pnas.95.7.4013","article-title":"Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons","volume":"31","author":"Saucedo-Cardenas","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib141","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/schbul\/sbp147","article-title":"Schizophrenia and 1957 pandemic of influenza: meta-analysis","volume":"36","author":"Selten","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib142","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1523\/JNEUROSCI.23-01-00297.2003","article-title":"Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring","volume":"23","author":"Shi","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib143","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.biopsych.2009.11.026","article-title":"Maternal influenza infection during pregnancy impacts postnatal brain development in the rhesus monkey","volume":"67","author":"Short","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib144","doi-asserted-by":"crossref","first-page":"10695","DOI":"10.1523\/JNEUROSCI.2178-07.2007","article-title":"Maternal immune activation alters fetal brain development through interleukin-6","volume":"27","author":"Smith","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib145","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/schbul\/sbn121","article-title":"Association between prenatal exposure to bacterial infection and risk of schizophrenia","volume":"35","author":"S\u00f8rensen","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib146","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0149-7634(00)00014-2","article-title":"The adolescent brain and age-related behavioral manifestations","volume":"24","author":"Spear","year":"2000","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib147","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.biopsych.2004.01.019","article-title":"Pervasive developmental disorder and childhood-onset schizophrenia: comorbid disorder or a phenotypic variant of a very early onset illness?","volume":"55","author":"Sporn","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib148","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s007020200075","article-title":"Exposure to prenatal infections, genetics and the risk of systematic and periodic catatonia","volume":"109","author":"St\u00f6ber","year":"2002","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib149","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/dev.20170","article-title":"The International Society for Developmental Psychobiology annual meeting symposium: impact of early life experiences on brain and behavioral development","volume":"48","author":"Sullivan","year":"2006","journal-title":"Dev. Psychobiol."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib150","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/oxfordjournals.schbul.a033326","article-title":"Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia","volume":"24","author":"Swerdlow","year":"1998","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib151","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-065X.2007.00562.x","article-title":"Recognition of viruses by innate immunity","volume":"220","author":"Takeuchi","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib152","series-title":"Neurobiology of Mental Illness","article-title":"Principles of pharmacotherapy in schizophrenia","author":"Tamminga","year":"1999"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib153","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.mp.4001563","article-title":"Phenotype of schizophrenia: a review and formulation","volume":"10","author":"Tamminga","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2009.03.005","article-title":"Schizophrenia, \u201cjust the facts\u201d 4. Clinical features and conceptualization","volume":"110","author":"Tandon","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib155","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/hmg\/9.6.953","article-title":"Dissection of behavior and psychiatric disorders using the mouse as a model","volume":"9","author":"Tarantino","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib156","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.lfs.2003.10.010","article-title":"Intratracheal double-stranded RNA plus interferon-gamma: a model for analysis of the acute phase response to respiratory viral infections","volume":"74","author":"Traynor","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib157","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0006-3223(99)00289-9","article-title":"Schizophrenia: genes and environment","volume":"47","author":"Tsuang","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib158","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.brainresrev.2006.01.006","article-title":"Animal models of behavioral dysfunctions: basic concepts and classifications, and an evaluation strategy","volume":"52","author":"van der Staay","year":"2006","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib159","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1744-9081-5-11","article-title":"Evaluation of animal models of neurobehavioral disorders","volume":"5","author":"van der Staay","year":"2009","journal-title":"Behav. Brain Funct."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib160","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/schbul\/sbn117","article-title":"Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions","volume":"34","author":"van Os","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib161","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1523\/JNEUROSCI.5408-09.2010","article-title":"A\u00a0longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia","volume":"30","author":"Vuillermot","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib162","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1006\/excr.1999.4691","article-title":"Fate of mesencephalic AHD2-expressing dopamine progenitor cells in Nurr1 mutant mice","volume":"253","author":"Wall\u00e9n","year":"1999","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib163","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/archpsyc.1987.01800190080012","article-title":"Implications of normal brain development for the pathogenesis of schizophrenia","volume":"44","author":"Weinberger","year":"1987","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib164","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0920-9964(95)00013-C","article-title":"Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground","volume":"16","author":"Weinberger","year":"1995","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib165","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00213-002-1313-x","article-title":"The \u201ctwo-headed\u201d latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment","volume":"169","author":"Weiner","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00427414","article-title":"The validity of animal models of depression","volume":"83","author":"Willner","year":"1984","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib167","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0278-5846(86)90051-5","article-title":"Validation criteria for animal models of human mental disorders: learned helplessness as a paradigm case","volume":"10","author":"Willner","year":"1986","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib168","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1017\/S1461145708009206","article-title":"Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia","volume":"12","author":"Winter","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib169","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bbr.2008.02.021","article-title":"Immune activation during mid-gestation disrupts sensorimotor gating in rat offspring","volume":"190","author":"Wolff","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib170","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bbr.2010.05.008","article-title":"The maternal immune activation (MIA) model of schizophrenia produces pre-pulse inhibition (PPI) deficits in both juvenile and adult rats but these effects are not associated with maternal weight loss","volume":"213","author":"Wolff","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib171","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/schbul\/sbm149","article-title":"Progressive changes in the development toward schizophrenia: studies in subjects at increased symptomatic risk","volume":"34","author":"Wood","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib172","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(00)00022-0","article-title":"Schizophrenia and HLA: a review","volume":"47","author":"Wright","year":"2001","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib173","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1176\/ajp.152.12.1714","article-title":"Maternal influenza, obstetric complications, and schizophrenia","volume":"152","author":"Wright","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib174","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.schres.2005.11.006","article-title":"Reduction of dopamine-related transcription factors Nurr1 and NGFI-B in the prefrontal cortex in schizophrenia and bipolar disorders","volume":"84","author":"Xing","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib175","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bbr.2008.11.049","article-title":"Distinct forms of prepulse inhibition disruption distinguishable by the associated changes in prepulse-elicited reaction","volume":"204","author":"Yee","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib176","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0920-9964(02)00323-7","article-title":"Perseveration and over-switching in schizophrenia","volume":"61","author":"Yogev","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib177","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.schres.2008.07.012","article-title":"Validation of \u201cprodromal\u201d criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up","volume":"105","author":"Yung","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2011.01.009_bib178","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.276.5310.248","article-title":"Dopamine neuron agenesis in Nurr1-deficient mice","volume":"276","author":"Zetterstr\u00f6m","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib179","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/sj.npp.1300248","article-title":"Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia","volume":"28","author":"Zuckerman","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib180","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s00213-003-1461-7","article-title":"Post-pubertal emergence of disrupted latent inhibition following prenatal immune activation","volume":"169","author":"Zuckerman","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2011.01.009_bib181","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jpsychires.2004.08.008","article-title":"Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring","volume":"39","author":"Zuckerman","year":"2005","journal-title":"J.\u00a0Psychiatr. Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811000128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811000128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T17:59:05Z","timestamp":1559930345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390811000128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":183,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0028390811000128"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.01.009","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}